A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer
Clinical trial NCT00548548 · COMPLETED
Trial details
- NCT number
- NCT00548548
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-11-01
- Enrollment
- 774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.